Project Grant F30CA301757
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded a Project Grant totaling $189,648 (awarded April 1, 2025; completion March 31, 2028) under the Cancer Research Manpower program (CFDA 93.398) to the University of Miami's Office of Research Administration—School of Medicine Division. This award supports a three-year biomedical research project investigating the mechanisms of mitochondrial biogenesis in T cell immunity, with particular focus on understanding how T...
- Federal Grant Award Summary The National Cancer Institute awarded The Johns Hopkins University a Project Grant totaling $510,431 under the Cancer Biology Research program (CFDA 93.396), effective July 1, 2025 through June 30, 2030. This award funds fundamental research investigating tumor dormancy and therapeutic resistance in melanoma within the context of aging. The research examines how age-related changes in the tissue microenvironment influence dormant melanoma cell reactivation at...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Johns Hopkins University a Project Grant of $147,486 under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective September 21, 2025, with completion anticipated by April 30, 2027. The research project, titled "Identifying Metabolic Targets to Reinvigorate T Cell Exhaustion," focuses on investigating metabolic pathways in CD8+ T cells to develop novel...
- Federal Grant Award Summary The National Cancer Institute awarded Johns Hopkins University $130,301 under the Cancer Cause and Prevention Research program (CFDA 93.393) effective September 5, 2025, through August 31, 2030. This Project Grant supports research leveraging extensions of the Surveillance, Epidemiology, and End Results (SEER)-Medicare database to examine real-world questions regarding high-quality cancer care delivery. The award funds biostatistical expertise and population-based...
- Federal Project Grant Award Summary The National Cancer Institute awarded $418,176 to Sloan-Kettering Institute for Cancer Research under the Cancer Biology Research program (CFDA 93.396) for a three-year project period commencing September 1, 2025, and concluding August 31, 2028. This Project Grant supports the advanced development and validation of programmable nucleic acid cytometry (NAC), a molecular technique designed to isolate and profile rare cell populations from tumors and tissues. The...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded The Johns Hopkins University a $354,658 Project Grant under the Cancer Biology Research program (CFDA 93.396) effective August 1, 2025, through July 31, 2030. This research initiative investigates subclonal P27 (CDKN1B) loss as a driver of aggressive prostate cancer in Black or African American (AA) males, who experience significantly higher mortality rates from the disease compared to European American (EA) males. The...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded a $223,176 Project Grant under the Cancer Research Manpower program (CFDA 93.398) to Duke University on September 10, 2025, with a completion date of April 30, 2028. This F32 postdoctoral fellowship award supports research investigating the role of SMARCAL1 (an annealing helicase) depletion in enhancing immunogenicity within Alternative Lengthening of Telomeres (ALT)-positive high-grade gliomas. The research addresses a...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded a Project Grant of $205,404 to The Trustees of Columbia University in the City of New York (Health Sciences Division) under the Cancer Research Manpower program (CFDA 93.398), effective September 6, 2025, with completion targeted for March 6, 2029. The award supports mechanistic and functional research investigating the impact of genomic variants on T cell anti-tumor activity, with the objective of enhancing the...
- Federal Project Grant Award Summary The Medical University of South Carolina received a $153,768 Project Grant from the National Cancer Institute (NCI) under the Cancer Research Manpower program (CFDA 93.398), awarded on September 10, 2025, with completion targeted for July 31, 2028. This award supports biomedical research training and investigation into peroxisome biogenesis in anti-tumor T cell metabolic fitness. The research focuses on understanding how peroxisome capacity influences T cell...
- Federal Project Grant Award Summary New York University School of Medicine received a $315,246 Project Grant from the National Cancer Institute under the Cancer Research Manpower program (CFDA 93.398) effective August 1, 2025 through July 31, 2030. The award funds a research project titled "Breaking Cytokine Loops in Lung Adenocarcinoma," which investigates the molecular mechanisms underlying poor immunotherapy responses in patients with LKB1 (liver kinase B1)-mutant lung...
The National Cancer Institute awarded The Johns Hopkins University a $109,076 Project Grant under the Cancer Research Manpower program (CFDA 93.398) effective January 16, 2026, with completion targeted for July 31, 2028. The research initiative, titled "Defining the Role of ACSS2 in T Cell Adaptation to Metabolic Stress," focuses on elucidating the function of acetyl-CoA synthetase 2 (ACSS2) as a metabolic checkpoint in T cell responses within tumor microenvironments. The project investigates how T cells adapt to metabolic stress conditions including hypoxia and nutrient depletion, which present significant barriers to anti-tumor immune responses and immunotherapy efficacy. The funded research delivers scientific investigation products through multiple research aims designed to characterize ACSS2's subcellular localization and function in T cells under metabolic stress conditions. Preliminary findings indicate that ACSS2 genetic loss causes excessive T cell proliferation and hyperactivation under hypoxic stress but paradoxically results in depletion of tumor-infiltrating lymphocytes in tumor models. The project will generate foundational knowledge regarding ACSS2's role as a metabolic sensor that integrates nutrient and oxygen availability with epigenetic gene expression changes, with potential implications for immunotherapy optimization and understanding T cell behavior in challenging immunological environments.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $54.5k | 7/15/25 | ||
| Not listed | $54.5k | 7/15/25 | ||
| Not listed | $0 | 7/15/25 | ||
| Not listed | $0 | 7/15/25 |